Biotech · Private company
Radiopharm Theranostics, Ltd
Track this companyFree. Adds Radiopharm Theranostics, Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- 177Lu-BetaBartPhase 2 · Castration-Resistant Prostate Cancer (CRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- BetaBart + unlabeled BetaBartPhase 2 · Castration-Resistant Prostate Cancer (CRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- RAD101 (18F-FPIA)Phase 2 · Brain Metastases From Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- RAD301 ([68Ga]-RAD301)Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Feb 23, 2026ClinicalTrials.gov NCT07189871 · fetched Nov 12, 2026
- Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain MetastasesPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 13, 2024ClinicalTrials.gov NCT06777433 · fetched Nov 12, 2026
- Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Nov 9, 2023ClinicalTrials.gov NCT05799274 · fetched Nov 12, 2026